Free Expression is a daily newsletter on American life, politics and culture from the Opinion pages of The Wall Street Journal. Sign up and start reading Free Expression today. Half of social science ...

A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential than researchers realized. Scientists at Scripps Research have discovered ...

Conducting research is hard; confirming the results is, too. And artificial intelligence isn’t yet ready to help, a major new study finds. By Carl Zimmer Carl Zimmer has reported on replication in ...

Tesla, SpaceX, and xAI have operations and projects that often overlap. SpaceX and xAI are already in the midst of merging. Tesla's high valuation implies investors are eyeing opportunities that go ...

March 26 (Reuters) - U.S. insurers Equitable (EQH.N), opens new tab and Corebridge Financial (CRBG.N), opens new tab said on Thursday they will merge in an all-stock deal that would create a $22 ...

"If it ain't broke, don't fix it," goes the old adage, which Rice University professor James Chappell completely ignored in a recent Nature Communications publication. In the study, Chappell describes ...

Paramount said it plans to merge HBO Max and Paramount+ into one streaming service after completing its WBD acquisition. Paramount executives didn't offer any details on pricing or what the service ...

The world of science has been stuck in an existential crisis over whether we actually know the things we thought we knew. Re-running an old study today doesn't always yield the same result. Same with ...

Elon Musk is merging his rocket company SpaceX with his artificial intelligence startup xAI. The merger is part of Musk's long-term plan to build data centers in space. Musk's Starship rocket is ...

Three of Elon Musk’s companies — SpaceX, xAI, and Tesla — are in play for a potential merger. While the talks appear to be in the early stage, according to reports from Bloomberg and Reuters, it could ...

Scientific progress depends on results that can be repeated – yet across disciplines, too many experiments fail that test. From medicine to economics, the replication crisis reveals not just flawed ...